5-Phenyl-1H-pyrazolo<4,3-b>pyridin | 52090-70-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 5-Phenyl-1H-pyrazolo<4,3-b>pyridin
• 英文别名: 5-phenyl-1H-pyrazolo[4,3-b]pyridine；5-phenyl-1H-pyrazolo[4,3-b]pyridine
• CAS: 52090-70-7
• 化学式: C₁₂H₉N₃
• 分子量: 195.224
• InChiKey: FXUDQKREGGIUQW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  41.6
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• 5-PHENYLPYRAZOLOPYRIDINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
  申请人：Auger Florian

  公开号：US20130023554A1

  公开（公告）日：2013-01-24

  Compounds of formula (I): in which: R1 represents a phenyl group or naphthyl group, optionally substituted by one or more atoms or groups chosen, independently of one another, from: halogen, (C 1 -C 6 )alkyl, halo(C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, halo(C 1 -C 6 )alkoxy, (C 1 -C 6 )thioalkyl, —S(O)(C 1 -C 6 )alkyl, —S(O) 2 (C 1 -C 6 )alkyl, hydroxyl, hydroxy(C 1 -C 6 )alkylene, CHO, COOH, (C 1 -C 6 )alkoxy(C 1 -C 6 )alkyleneoxy, NRaRb, CONRaRb, SO 2 NRaRb, NRcCORd, OC(O)NRaRb, OCO(C 1 -C 6 )alkyl, NRcC(O)ORe or NRcSO 2 Re; X represents from 1 to 4 substituents which are identical to or different from one another and which are chosen from hydrogen, halogen, (C 1 -C 6 )alkyl or (C 1 -C 6 )alkoxy, it being possible for the (C 1 -C 6 )alkyl to be optionally substituted by one or more groups chosen from a halogen, (C 1 -C 6 )alkoxy or hydroxyl; R2 and R3 represent, independently of one another, a hydrogen atom, a (C 1 -C 6 )alkyl group optionally substituted by an Rf group, or a CHO or COOH group; X and R3 can together form, with the carbon atoms which carry them, a carbocycle of 5 to 7 carbon atoms; R4 represents a hydrogen atom or a (C 1 -C 6 )alkyl group; Ra and Rb represent, independently of one another, a hydrogen atom or a (C 1 -C 6 )alkyl, aryl(C 1 -C 6 )alkylene or aryl group; or Ra and Rb together form, with the nitrogen atom which carries them, an azetidine, pyrrolidine, piperidine, azepine, morpholine, thiomorpholine, piperazine or homopiperazine group, this group being optionally substituted by a (C 1 -C 6 )alkyl, aryl or aryl(C 1 -C 6 )alkylene group; Rc and Rd represent, independently of one another, a hydrogen atom or a (C 1 -C 6 )alkyl, aryl(C 1 -C 6 )alkylene or aryl group; or Rc and Rd together form a (C 2 -C 5 )alkylene group; Re represents a (C 1 -C 6 )alkyl, aryl(C 1 -C 6 )alkylene or aryl group; or Rc and Re together form a (C 2 -C 5 )alkylene group; Rf represents a hydroxyl, oxo, CHO or COOH group, in the form of the base or of an addition salt with an acid. Therapeutic use and synthetic process.

  公式（I）的化合物：其中：R1代表苯基或萘基，可选择地被一个或多个独立选择的原子或基团取代，这些基团包括：卤素，（C1-C6）烷基，卤代（C1-C6）烷基，（C1-C6）氧烷基，卤代（C1-C6）氧烷基，（C1-C6）硫基烷基，—S（O）（C1-C6）烷基，—S（O）2（C1-C6）烷基，羟基，羟基（C1-C6）烷基烯基，CHO，COOH，（C1-C6）氧烷氧基，NRaRb，CONRaRb，SO2NRaRb，NRcCORd，OC（O）NRaRb，OCO（C1-C6）烷基，NRcC（O）ORe或NRcSO2Re；X代表1到4个取代基，这些取代基可以相同也可以不同，可以选择为氢，卤素，（C1-C6）烷基或（C1-C6）氧烷基，其中（C1-C6）烷基可以选择性地被一个或多个卤素，（C1-C6）氧烷基或羟基取代；R2和R3分别代表氢原子，可选择性地被Rf基团取代的（C1-C6）烷基基团，或CHO或COOH基团；X和R3可以与携带它们的碳原子一起形成5到7个碳原子的碳环；R4代表氢原子或（C1-C6）烷基基团；Ra和Rb分别代表氢原子或（C1-C6）烷基，芳基（C1-C6）烷基或芳基；或Ra和Rb可以与携带它们的氮原子一起形成氮杂环，例如氮杂丙烷，吡咯烷，哌咯烷，氮杂庚烷，吗啉，硫代吗啉，哌嗪或同半哌嗪基团，该基团可选择性地被（C1-C6）烷基，芳基或芳基（C1-C6）烷基基团取代；Rc和Rd分别代表氢原子或（C1-C6）烷基，芳基（C1-C6）烷基或芳基；或Rc和Rd可以一起形成（C2-C5）烷基基团；Re代表（C1-C6）烷基，芳基（C1-C6）烷基或芳基基团；或Rc和Re可以一起形成（C2-C5）烷基基团；Rf代表羟基，氧基，CHO或COOH基团，以碱或酸的加成盐形式存在。治疗用途和合成方法。
• DERIVES ACETYLENIQUES DE 5-PHENYL-PYRAZOLOPYRIDINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
  申请人：SANOFI

  公开号：EP2477988A1

  公开（公告）日：2012-07-25
• Dérivés acétyléniques de 5-phényl-pyrazolopyridine, leur préparation et leur application en thérapeutique
  申请人：SANOFI

  公开号：EP2477988B1

  公开（公告）日：2013-07-17
• DÉRIVÉS DE 5-PHENYL-PYRAZOLOPYRIDINE, LEUR PRÉPARATION ET LEUR APPLICATION EN THÉRAPEUTIQUE
  申请人：SANOFI

  公开号：EP2477990A1

  公开（公告）日：2012-07-25
• US8546424B2
  申请人：——

  公开号：US8546424B2

  公开（公告）日：2013-10-01